Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Versanis Bio ("Versanis"), a clinical-stage biopharmaceutical company advancing novel therapeutics for obesity and other cardiometabolic diseases,...
Versanis Bio ("Versanis"), a clinical-stage biopharmaceutical company advancing novel therapeutics for cardiometabolic diseases, today announced that ...
Versanis Bio ("Versanis"), a clinical-stage biopharmaceutical company advancing novel therapeutics for cardiometabolic diseases, today shares new...
Versanis Bio ("Versanis"), a clinical stage company advancing novel therapeutics for people living with obesity and cardiometabolic diseases, today...
Versanis Bio ("Versanis"), a clinical-stage company advancing novel therapeutics for cardiometabolic diseases, today announced three organizational...
Versanis Bio ("Versanis"), a clinical-stage company advancing novel therapeutics for cardiometabolic diseases, will share analysis of Phase 2 data...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.